Reliability and Validity of the Glittre Activities of Daily Living Test in Children and Adolescents With Juvenile Idiopathic Arthritis

Recruiting Observational Study
Juvenile Idiopathic Arthritis (JIA)
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
8 – 18
Sex
Any
Study type
Observational
Participants needed
80 (estimated)
Sponsor
Hacettepe University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Juvenile Idiopathic Arthritis (JIA) is children's most common inflammatory rheumatic disease. The International League of Associations for Rheumatology (ILAR) defines it as a chronic arthritis condition that begins before the age of 16 lasts for six weeks or more, and has an unknown cause. Despite the gains made in the management of the disease of individuals with JIA with modern medical treatment…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Being diagnosed with Juvenile Idiopathic Arthritis (JIA) according to The International League of Associations for Rheumatology (ILAR) classification * Being between the ages of 8-18 * Volunteering to participate in research Exclusion Criteria: * Advanced heart/lung/liver/ki…
Contacts

Sinan Buran, MSc

+905076393104

pt.sinanburan@gmail.com

CONTACT

Edibe Ünal, Prof.

+905327476706

edibeunal@yahoo.com

CONTACT